https://www.iongenomics.bio/p/grail-misses-revenue-estimates-asIon Genomicsen2026-11-06T22:21:35+00:00Grail Misses Revenue Estimates as Marketing Costs Surge: Q3 Earnings Rounduphttps://www.iongenomics.bio/p/guardants-shield-test-hits-83k-testsIon Genomicsen2026-11-06T19:19:49+00:00Guardant's Shield Test Hits 83K Tests in Q3, Driving 36 Percent Jump in Revenuehttps://www.iongenomics.bio/p/natera-appoints-new-ceo-makes-mysteryIon Genomicsen2026-11-06T00:03:50+00:00Natera Appoints New CEO, Makes Mystery $30M Acquisitionhttps://www.iongenomics.bio/p/10x-genomics-preps-for-atera-eraIon Genomicsen2026-11-05T23:37:38+00:0010x Genomics Preps for Atera Era Even as Spatial Instrument Revenue Dipshttps://www.iongenomics.bio/p/pacbio-reusable-consumables-salesIon Genomicsen2026-11-05T20:50:52+00:00PacBio Reusable Consumables Sales Grow, Enabling Project Wins in Q3https://www.iongenomics.bio/p/10x-genomics-debuts-claude-poweredIon Genomicsen2026-11-04T22:57:20+00:0010x's Anthropic Partnership Yields New Single-Cell Analysis Software: Newsletter, Nov. 4